We are live on
!
Find out more
VA
Verdad Advisers Portfolio holdings
AUM
$104M
This Fund
S&P 500
This Quarter
Est. Return
+21.07%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
+$15.6M
(+18%)
Cap. Flow
+$3.28M
Cap. Flow
% of AUM
3.14%
Top 10 Holdings %
Top 10 Hldgs %
18.12%
Holding
276
New
97
Increased
59
Reduced
42
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.13M |
| 2 |
Protara Therapeutics
TARA
|
+$1.49M |
| 3 |
X4 Pharmaceuticals
XFOR
|
+$1.44M |
| 4 |
Tyra Biosciences
TYRA
|
+$1.19M |
| 5 |
JBIO
Jade Biosciences
JBIO
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.57M |
| 2 |
Revolution Medicines
RVMD
|
+$2.56M |
| 3 |
State Street
STT
|
+$2.11M |
| 4 |
Autohome
ATHM
|
+$2.11M |
| 5 |
Cal-Maine
CALM
|
+$1.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.7% |
| 2 | Technology | 15.71% |
| 3 | Financials | 9.07% |
| 4 | Communication Services | 7.06% |
| 5 | Consumer Discretionary | 5.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Viatris
VTRS
$19.5B
| $516K | 0.49% |
32,500
| – | – |
|
77
InnovAge Holding
INNV
$1.46B
| $499K | 0.48% |
42,139
+10,498
| +33% | +$86K |
|
|
MOMO
78
Hello Group
MOMO
$674M
| $491K | 0.47% |
84,685
-64,568
| -43% | -$385K |
|
79
PMV Pharmaceuticals
PMVP
$66.3M
| $486K | 0.47% |
362,361
+182,200
| +101% | +$234K |
|
80
National Healthcare
NHC
$3.47B
| $485K | 0.46% |
+2,295
| New | +$421K |
|
81
Cirrus Logic
CRUS
$5.67B
| $485K | 0.46% |
3,265
+28
| +0.9% | +$4.58K |
|
|
82
Micron Technology
MU
$1.08T
| $484K | 0.46% |
419
-3,422
| -89% | -$2.57M |
|
83
Jones Lang LaSalle
JLL
$16.7B
| $481K | 0.46% |
1,552
-1,611
| -51% | -$501K |
|
84
APA Corp
APA
$15.5B
| $474K | 0.45% |
+14,562
| New | +$547K |
|
85
The RMR Group
RMR
$331M
| $462K | 0.44% |
+22,496
| New | +$426K |
|
86
Fulcrum Therapeutics
FULC
$293M
| $458K | 0.44% |
+125,224
| New | +$762K |
|
87
PROG Holdings
PRG
$1.53B
| $437K | 0.42% |
9,382
-12,917
| -58% | -$451K |
|
|
SEPN
88
Septerna Inc
SEPN
$1.72B
| $434K | 0.42% |
+12,970
| New | +$368K |
|
|
BIOA
89
BioAge Labs
BIOA
$436M
| $426K | 0.41% |
17,394
+2,184
| +14% | +$39.5K |
|
90
Teradyne
TER
$52.9B
| $425K | 0.41% |
878
-1,138
| -56% | -$429K |
|
91
Arrow Electronics
ARW
$10.7B
| $422K | 0.4% |
1,976
-344
| -15% | -$68.7K |
|
92
Ingles Markets
IMKTA
$1.57B
| $419K | 0.4% |
+4,734
| New | +$423K |
|
93
Erasca
ERAS
$5.69B
| $411K | 0.39% |
22,460
-10,610
| -32% | -$152K |
|
94
Viant Technology
DSP
$284M
| $404K | 0.39% |
+31,880
| New | +$359K |
|
95
Qualcomm
QCOM
$180B
| $399K | 0.38% |
+2,161
| New | +$404K |
|
96
Shattuck Labs
STTK
$699M
| $397K | 0.38% |
57,231
+43,853
| +328% | +$274K |
|
97
Zura Bio
ZURA
$563M
| $395K | 0.38% |
66,919
-30,183
| -31% | -$144K |
|
98
Lam Research
LRCX
$366B
| $387K | 0.37% |
893
-4,270
| -83% | -$1.3M |
|
99
Savara
SVRA
$1.1B
| $380K | 0.36% |
61,759
-66,617
| -52% | -$358K |
|
|
MAZE
100
Maze Therapeutics
MAZE
$1.44B
| $377K | 0.36% |
+12,618
| New | +$331K |
|
Similar funds
IAP
JRSI
SFG
TPW
ACM
TOTUOP
XFP
ICVCFVA
Verdad Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Verdad Advisers held 276 positions worth $104M, up 18% from $88.8M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Verdad Advisers deployed $3.28M of net new capital in Q2 2026, opening 97 new positions and adding to 59 existing holdings. Its largest new stake was Apple: 7,445 shares worth $2.15M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 42% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.57M trimmed.
- Verdad Advisers's largest Q2 2026 buy was Apple: 7,445 shares worth $2.15M.
- Verdad Advisers added most to Comcast in Q2 2026, an estimated $1.11M increase.
- Verdad Advisers's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.57M.
- Verdad Advisers fully exited State Street in Q2 2026, selling an estimated $2.11M.
- Verdad Advisers's ten largest holdings make up 18% of its $104M portfolio in Q2 2026.
- Verdad Advisers opened 97 new positions and closed 66 in Q2 2026.
- Verdad Advisers's portfolio value rose 18% quarter-over-quarter to $104M.
Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.